Symptomatic Aortic Stenosis Clinical Trials
2 recruiting trials for Symptomatic Aortic Stenosis. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Symptomatic Aortic Stenosis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 4 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by Insel Gruppe AG, University Hospital Bern (1), Second Affiliated Hospital, School of Medicine, Zhejiang University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Structured SDM (other, 1 trial), followed by Usual Care, transcatheter aortic valve replacement.
Track Symptomatic Aortic Stenosis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Structured Shared Decision Making for Patients Undergoing SAVR or TAVR
Transcatheter aortic valve replacement (TAVR) is a well-established alternative to surgical aortic valve replacement (SAVR) for the treatment of patients with severe aortic...
Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population
The purpose of this study is to evaluate the safety and effectiveness of transcatheter aortic valve replacement in Chinese population.
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Symptomatic Aortic Stenosis, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Symptomatic Aortic Stenosis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Symptomatic Aortic Stenosis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.